FUNDING SCHEME Sample Clauses
The FUNDING SCHEME clause defines the method and structure by which financial resources will be provided for a project or agreement. It typically outlines the sources of funding, the schedule of payments, and any conditions or milestones that must be met to trigger disbursements. For example, it may specify that funds are released in stages upon completion of certain deliverables or according to a pre-agreed timeline. The core function of this clause is to ensure transparency and predictability in the flow of funds, thereby reducing financial uncertainty and aligning expectations between the parties involved.
FUNDING SCHEME. (subclause 1.1) Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme This scheme is conducted by Cancer Australia in conjunction with the National Health and Medical Research Council
FUNDING SCHEME. The following payment scheme will apply: - 25% of the agreed upon funding will be provided at the time the contract is signed. - Based on the evaluation of the final report, a payment of up to 50% of the requested funding will be carried out by the SoftFIRE project coordinator. - The remaining 25% will be paid following the formal approval of the final report and corresponding work by the European Commission (EC).
FUNDING SCHEME. The Placement Provider will be reimbursed by NHS England a contribution to training which will be paid according to the NHS England Funding Guide and associated regional agreements for funding (for the NHS managed sector). NHS England will reimburse the Placement Provider at a rate agreed annually and set out in accordance to Schedule 2, covering a period of 24 months, and aligned to correspondence previously provided by NHS England confirming the commission of PTPTs. Funding will be discontinued in advance if a PTPT is no longer in receipt of their salary due to dismissal, resignation, or extended leave. In the event of the Placement Provider being unable to deliver the training to the required standard thereby resulting in an individual PTPT being transferred to a different organisation, NHS England will manage any changes and funding will be transferred to the new placement provider as necessary. No other expenses, such as education course fees, PTPT’s travel expenses, will be reimbursed to the employing placement Provider. This provision will commence on the start date of each PTPT and continue for a period of 24 months of full-time training. The exception to this would be a PTPT who in exceptional circumstances has an extension to training approved by NHS England. Funding for activities described in section 19 is available only for the 2024/25 financial year. Funding for activity in subsequent years is subject to confirmation. The Newly Qualified Pharmacist Programme (NQP) supports (registered) newly qualified pharmacists to develop their knowledge and skills in practice, with associated funding for 12 months duration of Educational Supervision within their employing organisation. NHS England separately provide access to an e-portfolio, professional framework and learning materials. The Placement Provider is the employer of a newly qualified pharmacist that has enrolled on the Newly Qualified Pharmacist Programme, and where that placement provider has an internal newly qualified pharmacist support programme that has been approved by NHS England WT&E as appropriate. Eligibility is determined by a Placement Provider that employs a newly qualified pharmacist, has an internally newly qualified pharmacist support programme that has been approved by NHS England WT&E, and has identified the newly qualified pharmacist to the NHS England WT&E regional team for newly qualified pharmacists in the NHS Managed Sector, and the NHS England WT&E National Pharmacy Tea...
FUNDING SCHEME. The Student is benefiting from a JMD scholarship Partner country/Programme Country
a) By signing this contract, the student acknowledges the acceptance of the JMD scholarship for the European Joint Master Degree in Neuroscience ‘Neurasmus’
b) The student understands that he/she will receive a scholarship for the academic years 20XX / 20XX according to the following scheme: €18,000 (Partner country scholarship) or € 9,000 (Programme country scholarship) will be deducted automatically to cover EMJMD participation costs for the 2 years; The remaining sum will be paid out by bank transfer in monthly instalments over the course of the academic year following the receipt of details for his/her French bank account.
c) The scholarship will be used only for the coverage of study-related travel expenditures, subsistence costs and participation costs including tuition fees, incurring during his/her participation in the Joint Master Degree Programme.
FUNDING SCHEME. The Student is benefiting from an EMJMD scholarship Programme/Partner country
a) By signing this contract, the student acknowledges the acceptance of the EMJMD scholarship for the European Joint Master Degree in Neuroscience ‘Neurasmus’
b) The student understands that he/she will receive a scholarship for the academic years 2018 / 2020 according to the following scheme: Contribution to subsistence costs: 1,000€ / month for a total of 24 instalments starting from September n until August n+2, Contribution to travel and installation: 1,000 € /year per scholarship holder resident in a Programme Country for travel costs 2,000 € /year for travel costs + 1 000 EUR for installation costs for scholarship holder resident in a Partner Country whose location is situated at less than 4.000 km from the EMJMD coordinating HEI 3,000 € per year for travel costs + 1 000€ for installation costs for scholarship holder resident in a Partner Country whose location is situated at 4.000 km or more from the EMJMD coordinating HEI. For a total of: total amount of the scholarship The sum will be paid out by bank transfer in monthly instalments over the course of the academic year following the receipt of details for the student bank account (SEPA zone). The contribution to travel is paid in 2 instalments, each one at the beginning of each academic year. The contribution to installation is paid in one instalment at the beginning of the programme.
c) The scholarship will be used only for the coverage of study-related travel expenditures, subsistence costs and participation costs including tuition fees, incurring during his/her participation in the Erasmus Mundus Joint Master Degree Programme.
FUNDING SCHEME. 8.1 - General payment terms and benefficiaries’ obligations
FUNDING SCHEME. 1. The Participants will endeavour to make the necessary funds and other resources for the implementation of the cooperative activities with regards to the Participants’ respective commitments in line with the Memorandum and/or the Work Plan, taking into account the capacity of the Participants.
2. Any costs of the cooperative activities under the Memorandum and/or the Work Plan will be borne in manner to be mutually decided by the Contact Points.
FUNDING SCHEME. The Student is benefiting from a Self-funding candidate Partner country/Programme Country
a) By signing this contract, the student acknowledges the acceptance of the Self-funding position for the European Joint Master Degree Programme in Neuroscience ‘Neurasmus’ and certifies that he/she has adequate funds to pursue the full Program.
b) No financial assistance from the Erasmus Mundus Joint Master Degree Program will be provided towards payments of either fees or maintenance/travel costs during the period of study of the MSc in Neuroscience.
c) The student will pay his/her participation costs according to the category he/she belongs. Transfers will be done directly to the Neurasmus Secretariat in one instalment each year: € 9,000 per year (Partner country)/ € 4,500 per year (Programme country) The transferred money will be used only for the coverage tuition fees and other study-related costs, incurring during his/her participation in the Joint Master Programme.